


13therapeutics Revenue
Biotechnology Research • Portland, Oregon, United States • 1-10 Employees
13therapeutics revenue & valuation
| Annual revenue | $342,220 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $1,100,000 |
| Total funding | $3,000,000 |
Key Contact at 13therapeutics
Sharon Mccoy
Vice President
Company overview
| Headquarters | 2611 SW 3RD AVE, PORTLAND, OR 97201, US |
| Phone number | +15035254887 |
| Website | |
| SIC | 283 |
| Keywords | Drug Development |
| Founded | 2008 |
| Employees | 1-10 |
| Socials |
13therapeutics Email Formats
13therapeutics uses 1 email format. The most common is {first initial} (e.g., j@13therapeutics.com), used 100% of the time.
| Format | Example | Percentage |
|---|---|---|
{first initial} | j@13therapeutics.com | 100% |
About 13therapeutics
13therapeutics is a research and drug development company identifying and characterizing novel anti-inflammatory peptide therapeutics for unmet medical needs with high commercial potential. The company has an innovative platform for discovering and enhancing peptides, derived from naturally occurring pathogens (e.g., bacteria, viruses, fungi), which modulate the human immune response. This platform has produced a portfolio of peptides with demonstrated immune-regulatory activity and with varying mechanisms of action. These peptides have potential application for treatment of both acute and chronic inflammatory diseases. Many of the company’s peptides are capable of multiple methods of delivery, have shown serum stability, and have other desired features clinical therapeutics. Target conditions include the treatment of acute inflammatory diseases such as Acute Otitis Media (AOM), Systemic Inflammation, Meningitis, Traumatic Brain Injury (TBI), Uveitis and Ischemia. We are also evaluating peptides in chronic models for Lupus, Rheumatoid Arthritis (RA), Multiple Sclerosis, Atherosclerosis, Crohn’s Disease and Psoriasis, among others. Using our evolution-based methodology, we envision rapid development across several disease states.
Employees by Management Level
Total employees: 1-10
Seniority
Employees
13therapeutics Tech Stack
Discover the technologies and tools that power 13therapeutics's digital infrastructure, from frameworks to analytics platforms.
JavaScript libraries
Hosting
CMS
Miscellaneous
Frequently asked questions
4.8
40,000 users



